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Purpose: To investigate the utility of opposed-phase magnetic resonance imaging (OP MRI) in differ-
entiating malignant from benign bone lesions.
Materials and methods: MRI scans of musculoskeletal lesions including opposed-phase imaging se-
quences were reviewed by both an experienced musculoskeletal attending radiologist, and a second year
radiology resident. The change in signal from IP to OP images was measured. The reviewers' evaluation of
the lesions based on T1 and T2-weighted images was compared to their evaluation with inclusion of the
OP sequences.
Results: Twenty-seven lesions in bone were analyzed: 4 malignant primary bone lesions, 3 malignant
soft tissue lesions to bone, 3 metastases from visceral malignancies, and 17 benign bone lesions. Benign
lesions of bone dropped in signal on OP imaging by an average of 37.1%. Five of the benign lesions
decreased in signal by less than 20%, and two increased. Malignant bone lesions dropped in signal by an
average of 0.69% with one of the ten lesions showing a greater than 20% drop.
When OP sequences were included, concern for malignancy decreased in benign lesions and in-
creased in malignant lesions, for both the resident and attending. Compared with standard MRI, inclu-
sion of these sequences increased the overall conﬁdence in diagnosis for both reviewers.
Conclusion: Opposed-phase imaging is helpful in differentiating benign from malignant lesions in bone.
Conﬁdence in diagnosis rose for both the attending and the resident as result of the inclusion of OP
sequences.
& 2015 The Authors. Published by Elsevier GmbH. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Magnetic resonance imaging (MRI) has great utility in evalu-
ating musculoskeletal tumors. However, some lesions have an
appearance on MRI that make it challenging to differentiate be-
nign from malignant lesions. Even intravenous (IV) contrast
sometimes does not allow differentiation of benign from malig-
nant lesions: hemangiomas, Schmorl's nodes, and degenerative
vertebral endplate changes all enhance with IV contrast. Opposed-
phase MRI (also termed chemical shift imaging, or in-and-out of
phase imaging) has shown value in this setting based on its abilityGmbH. This is an open access art
ing, Room 516, Philadelphia,
te.com (B.E. Kenneally),
c.psu.edu (A.W. Reynolds),
on),to detect small amounts of fat, suggestive of a benign process. In
these opposed-phase sequences, signal characteristics consistent
with normal fat tissue are not found in malignant, marrow-re-
placing bone lesions [1,2].
This imaging technique exploits the difference in signal seen on
in-phase (IP) and out-of-phase (OP) sequences: this difference is
based on the phenomenon that hydrogen atoms attached to water
and lipid precess at different frequencies. On the in-phase imaging,
fat and water signals are additive when these tissues are in the
same voxel. On OP images, the two vectors are opposite, resulting
in the two signals canceling. When lipid and water exist simulta-
neously in a benign lesion, the result is a drop in signal on OP
images when compared to IP images of the same lesion (see
Fig. 1a–d). IP and OP sequences are easily acquired during a
standard musculoskeletal protocol, using a dual gradient-echo
technique with T1 weighting. Protocol for IP and OP MRI differs
depending on the strength of the magnetic ﬁeld: with a 1.5 T
magnet, the interval on TE (time to echo) between IP and OPicle under the CC BY-NC-ND license
Fig. 1. a–d: 1a – Sagittal T1-weighted spin echo (SE); TR: 500 ms, TE: 9 ms. 1b – T2-weighted fast spin echo (FSE); TR: 4600 ms, TE: 88 ms. 1c – In-phase gradient-recalled
echo (GRE): TR: 125 ms, TE: 4.6 ms, ﬂip angle: 90°. 1d – coronal opposed-phase gradient-recalled echo (GRE): TR: 125 ms; TE: 2.3 ms, ﬂip angle: 90°.
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imaging can be taken in about 20–30 s, or a single breath hold.
Many benign bone lesions contain variable amounts of fat,
while malignant bone lesions replace or destroy the fatty bone
marrow. A drop in signal on OP images indicates at least some fat
content in the lesion, suggestive of a benign process (see Fig. 2a–
d). Imaging software uses a region of interest (ROI) to measure the
drop in signal, thus yielding a quantitative result. Previous studies
have determined a drop in signal of 20% or more to be suggestive
of a benign lesion [3]. A drop of 20% on OPI was found to capture
all malignant lesions in the study, although this cut-off did allow
for some benign lesions being included in the malignant category
[3]. This 20% threshold seems to maximize the sensitivity and
speciﬁcity of the test. A malignant lesion tends to contain little or
no fat, resulting in little drop in signal from in-phase to out-of-
phase sequences (see Fig. 3a–d). Previous research has shown that
this correlates to the histology of the lesions [3]. The hypothesis of
our study is that these sequences may play an important role in
the imaging of musculoskeletal tumors, enhancing the ability to
differentiate benign from malignant disease states and in some
cases obviating the need for biopsy. Our goal is to investigate and
quantify the extent of this capability, using data collected from
blinded radiologists regarding their concern for malignancy, ac-
curacy in diagnosis, and conﬁdence in reading these imaging
studies.2. Materials and methods
Institutional review board approval was obtained for this
study; informed consent was waived as this is a retrospectiveFig. 2. a–d: 2a – Coronal T1-weighted SE; TR: 547 ms, TE: 12 ms. 2b – Coronal short tau
Coronal in-phase GRE; TR: 206 ms, TE: 4.6 ms, ﬂip angle: 70°. 2d – Coronal opposed phreview. A keyword search of our institutional radiology informa-
tion system was performed, querying for the phrases, “opposed
phase” and “in and out of phase.” A senior musculoskeletal radi-
ologist reviewed all MRIs to determine that the OP images were
adequate for analysis. Twenty-seven lesions meeting these criteria
were found.
Clinical records were examined to determine whether the le-
sions were benign or malignant. Inclusion criteria were either
biopsy conﬁrmation of lesions or at least 9 months of radiologic
surveillance. In patients who underwent biopsy, tissue diagnosis
was recorded; in those who did not undergo biopsy, documenta-
tion of clinical follow-up was utilized. Fifteen of the 27 patients
had a biopsy-proven diagnosis of malignancy; only 10 of these
exhibited bony involvement. Five of these were bone sarcoma and
another ﬁve were soft tissue sarcoma or visceral carcinoma. One of
the malignant lesions in bone represented direct, local invasion
from a soft tissue mass. Of the 17 benign lesions, two were biopsy-
proven (osteoid osteoma) and the other 15 were deemed benign
based on lack of progression with follow-up imaging and ex-
amination of at least nine months. Duration of follow-up imaging
ranged from nine to twenty-three months.
A senior musculoskeletal radiologist screened all cases and
presented them to two other radiologists in a blinded fashion.
These two radiologists were of different experience levels: one
was a musculoskeletal radiologist with 5 years of experience and
the other was a second-year radiology resident. The screening
radiologist had access to the patient records and radiology reports.
The two reviewers were blinded to the previous radiology reports
as well as the clinical diagnoses.
All MR imaging was performed by using a 1.5 T unit (various
vendors) and a phased-array surface coil. The following pulseinversion recovery (STIR); TR: 3830 ms, TE: 50 ms, inversion time (TI): 150 ms. 2c –
aseGRE; TR: 206 ms, TE: 2.3 ms, ﬂip angle: 70°.
Fig. 3. a–d: 3a: Axial T2-weighted FSE with fat suppression showing large soft tissue mass; TR: 4551 ms, TE: 67 ms. 3b: Coronal T1-weighted SE of pelvic metastasis; TR:
684 ms, TE: 12ms. 3c: Axial in-phase GRE; TR: 213 ms, TE: 4.6 ms, ﬂip angle: 80°. 3d: Axial opposed phaseGRE: TR: 206 ms, TE: 2.3 ms, ﬂip angle: 70°.
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stitutional protocol: T1-weighted spin-echo (400–700/8–16 [re-
petition time ms/echo time ms]) and fat-suppressed T2-weighted
fast spin-echo (2000–5000/80–100, with an echo train length of 8)
sequences, followed by in-phase (100–165/4.6; ﬂip angle, 30°) and
out-of-phase (100–165/2.3; ﬂip angle, 30°) fast multiplanar
spoiled gradient-echo sequences acquired using Dixon technique.
Apart from TE, all other parameters were held constant for ac-
quisition of in-phase and out-of-phase images. The ﬁeld of view
for exams varied depending on coverage required for the body
area being scanned; the acquisition matrix was typically
256192, and the section thickness and gap were typically
4.0 mm, with a skip of 1.0 mm.
Initially the standard T1 and T2-weighted images were re-
viewed. The reviewers evaluated the lesions for concern for ma-
lignancy on a scale of 0–5 (0¼no concern, 1¼minimal concern,
2¼slight concern, 3¼moderate concern, 4¼substantial concern,
and 5¼major concern) and for conﬁdence of benign vs. malignant
nature (0¼no conﬁdence, 1¼very unconﬁdent, 2¼mild con-
ﬁdence, 3¼moderately conﬁdent, 4¼very conﬁdent, and
5¼complete conﬁdence). This was followed by repeat review of
the same patients with opposed-phase sequences included. The
change in signal from IP to OP images was measured using region-
of-interest (ROI) quantitative measurements. Lesions were cate-
gorized again using the scales above. Results were compared to
biopsy results (when available) and follow-up imaging.3. Results
Twenty-seven bone lesions were analyzed in 27 patients.
Twelve of the patients were female and 15 were male. The mean
age of the patients was 58 years with a range of 21–84 years. Ten
lesions were determined to be malignant and 17 benign. Benign
lesions of bone dropped in signal on out-of-phase imaging by an
average of 37.1% (range 4–82.3%) when compared to in-phase-
imaging. Five of the 17 benign lesions (29%) decreased in signal byless than 20%. Two benign lesions showed an increase in signal
suggesting hemorrhage, consistent with osteoporotic compression
fracture or edema. There were 10 malignant bone lesions, which
dropped in signal by an average of 0.69% (range 2.9–49.8%). Six of
these lesions demonstrated a rise in signal. Only one of the 10
malignant lesions showed a greater than 20% drop; this outlier
represents bony extension of a soft tissue sarcoma, in a patient
approximately 1 month postoperative from resection of her soft
tissue mass. The abnormally large drop in signal may be explained
by postoperative bony edema in the area of resection (see Table 1).
When evaluating standard MRI sequences (standard T1 and T2)
concern for malignancy in benign lesions was 2.95 and 1.79 for
resident and attending, respectively (see Table 2). This decreased
to 2.11 and 1.47 with the addition of opposed-phase sequences.
Concern for malignancy in malignant lesions was 3.78 and 4.11 for
radiology resident and staff, respectively. This increased to 4.56
and 4.56 with the addition of opposed-phase sequences. Com-
pared with standard MRI, overall conﬁdence in diagnosis in-
creased from 3.36 to 4.29 for the radiology resident with the ad-
dition of OP sequences and from 3.96 to 4.43 for the radiology
attending.4. Discussion
The merit of opposed-phase MRI imaging in characterizing and
diagnosing bone lesions has been suggested in recent years [3–5].
The value of this technique has been shown in differentiating
benign spine fractures from pathologic fractures [5]. It has also
been used to identify lipid-containing adrenal adenomas and liver
tumors [6,7]. The goal of our study was to investigate the en-
hancement of diagnostic capability in musculoskeletal oncology as
result of this additional MRI sequence, as well as to explore any
resultant difference in conﬁdence in diagnosis for the radiologist.
Our ﬁndings showed that this technique is a useful additional tool
for differentiating between benign and malignant bone lesions,
and utilization of this technique did signiﬁcantly improve the
Table 1
Clinical information regarding lesions.
Patient Age Gender Lesion location Diagnosis Change in signal
Malignant lesions in bone
1 83 F Right acetabulum Pelvic chondrosarcoma 17.8% Rise
2 84 F T8 Metastatic carcinoma 5.1% Rise
3 66 M T12 Metastatic epithelioid malignancy 2.9% Drop
4 62 F Left ilium Metastatic carcinoma 14.1% Rise
5 57 F Right acetabulum Lymphoma 8.9% Rise
6 74 M Left posterior ilium Large B-cell lymphoma 14.2% Drop
7 65 F Right iliac crest Multiple myeloma 10% Rise
8 35 F Left femoral neck Leiomyosarcoma of great vessels 11.1% Rise
9 51 F Proximal humerus Extension of soft tissue sarcoma 49.8% Drop
10 83 M R proximal femur Metastatic high-grade soft tissue sarcoma with myxoid change 7% Drop
Average 0.69% Drop
Benign lesions in bone
11 65 M Distal femur Normal marrow adjacent to myxoid liposarcomaa 33% Drop
12 83 F T12 Hemangioma with history of metastatic carcinomaa 58% Drop
13 64 F Right proximal femur Metastatic sarcomaa 68.9% Drop
14 53 M Femoral shaft Normal marrow, with adjacent metastatic leiomyosarcomaa 40.3% Drop
15 52 M Iliac crest Post-op bone marrow changes, adjacent chondrosarcomaa 46% Drop
16 21 M Sacrum Osteoid osteoma 4.2% Rise
17 60 M T9 Compression fracture, benigna 28.7% Rise
18 62 M L2 Osteoid osteoma 46.5% Drop
19 75 M L2 Fracturea 64.4% Drop
20 47 M L5 Presumed atypical hemangiomaa 4.1% Drop
21 54 M T1 Presumed hemangiomaa 9.4% Drop
22 34 M T–L junction Presumed atypical hemangiomaa 68.1% Drop
23 58 F L4 Presumed hemangiomaa 51.1% Drop
24 58 F L5 Presumed hemangiomaa 4% Drop
25 44 M Diffuse marrow Presumed marrow heterogeneitya 71.3% Drop
26 46 F Posterior ilium Presumed marrow abnormalitya 15.6% Drop
27 30 M Diffuse marrow Presumed marrow abnormality, no discrete lesionsa 82.3% Drop
Average 37.1% Drop
This table demonstrates the clinical information regarding the 27 patients, including the change in signal of the lesion on opposed-phase imaging. The average for the signal
changes of malignant and benign groups is shown.
a These diagnoses were made based on history, physical exam, and imaging characteristics and were followed by sequential MRI scans; biopsy was not performed. The
remaining lesions without a were diagnosed with biopsy.
Table 2
Impact of OP MRI on radiologist interpretation.
Concern in benign
cases
Concern in malignant
cases
Conﬁdence in
diagnosis
T1/T2 only
Resident 2.95 3.78 3.36
Attending 1.79 4.11 3.96
Addition of opposed phase
Resident 2.11 4.56 4.29
Attending 1.47 4.56 4.43
This table demonstrates the effect that the addition of opposed phase imaging
sequences has on radiologists' ability to correctly interpret MRI scans of the lesions
in question. As illustrated, their accuracy in diagnosing malignant lesions, as well as
their conﬁdence in this diagnosis, improved with the addition of opposed phase
sequences.
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clinical and ﬁnancial value of this technique is important to con-
sider, as the ability to conﬁdently identify benign lesions from
malignant ones can obviate the need for unnecessary biopsies and
surgical procedures (see Fig. 4a–d).
One of the benign lesions in our study, an acute compression
fracture, showed a considerable increase in signal on OP imaging.
This was due to hemorrhage and illuminates an important caveat
when using this technique: in the acute phase, blood products can
result in an increase in signal intensity on OP imaging. The STIR
and T2 sequences are critical in elucidating this nuance, and it is
important for the clinician to realize that opposed-phase imagingshould be used with caution in evaluating lesions that are prone to
hemorrhage. One osteoid osteoma also demonstrated an increase
in signal, which could be explained by the intense edema sur-
rounding the nidus. Soft tissue sarcoma metastasis to bone oc-
curred in one patient who demonstrated a high magnitude of drop
in signal on OP sequences, likely due to her postoperative state
and resultant bony edema. This represents one of the limitations of
this imaging technique: while it is a fairly reliable predictor of
bone malignancy, the threshold of a 20% drop in signal is not
completely generalizable to malignancy in bone.
The impact of opposed phase imaging on radiologist conﬁdence
was an interesting ﬁnding of this study. In terms of conﬁdence in
their diagnosis of a benign versus malignant lesion, the presence
of opposed phase images for review certainly improved the
reader's conﬁdence. However, inappropriate conﬁdence could lead
to inaccurate diagnoses and devastating clinical consequences. In
the case of acute hemorrhage, for example, there are nuances of
these MRI techniques that must be understood to ensure accurate
and appropriate interpretation of their results. It is also important
to note that opposed-phase imaging is not a stand-alone techni-
que. Ideally these sequences would be incorporated into a holistic
review of all T1, T2, and TE MRI sequences, with contrast en-
hancement when appropriate, which have better resolution due to
better spatial orientation and lower signal-to-noise ratio.
There are several limitations to our study. The sample size is
low, partly due the relative rarity of sarcoma and also to the rarity
of the chemical shift imaging sequences being performed in our
study subjects. As a retrospective review, the authors were limited
to the patients' images available, performed at a prior date. Some
Fig. 4. a–d: 4a: Axial proton-density weighted; TR: 2173 ms, TE: 40 ms. 4b: Axial T2 fat-suppressed FSE; TR: 2518 ms, TE: 70 ms. 4c: Coronal in-phase GRE: TR: 234 ms, TE:
4.6 ms, ﬂip angle: 80°. 4c: Coronal opposed-phase GRE: TR: 234 ms, TE: 2.3 ms, ﬂip angle: 80°.
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so there was variability in equipment and imaging parameters.
However all images were reviewed for adequacy by an experi-
enced musculoskeletal radiologist who was not a reviewing radi-
ologist in the study. Another weakness of any retrospective review
is the possibility of selection bias, as the study sample may be an
inappropriate representation of the overall population. Future re-
search could be directed towards investigating the comparative
efﬁcacy of opposed phase MRI to that of contrast-enhanced MRI,
which is currently a highly-utilized technique for imaging mus-
culoskeletal tumors, as this was not speciﬁcally explored in this
study.5. Conclusion
It is the authors' belief that opposed-phase imaging is useful
additional tool in evaluating bone tumors. It improves diagnostic
accuracy and this results in higher conﬁdence level on the part of
radiologists attempting to diagnose these lesions and convey an
appropriate sense of concern for malignancy. Further study is
needed on the accuracy and reliability of this technique in a larger
heterogeneous group of patients with bone lesions, to more ef-
fectively quantify the tests’ true accuracy, precision, negative
predictive value, and positive predictive value. However, we urgeall orthopaedic surgeons ordering MRI scans on bone lesions to
consider this additional sequence to help guide their diagnosis and
management of patients.References
[1] S.K. Thawait, M.A. Marcus, W.B. Morrison, R.A. Klufas, J. Eng, J.A. Carrino, Re-
search synthesis: what is the diagnostic performance of magnetic resonance
imaging to discriminate benign from malignant vertebral compression frac-
tures? Systematic review and meta-analysis, Spine 37 (2012) e736–e744.
[2] M.J. Kransdorf, M.D. Bridges, Current developments and recent advances in
musculskeletal tumor imaging, Sem. Musculoskel. Radiol. 17 (2013) 145–155.
[3] C.A. Kohl, F.S. Chivers, R. Lorans, C.C. Roberts, M.J. Kransdorf, Accuracy of che-
mical shift MR imaging in diagnosing indeterminate bone marrow lesions in
the pelvis: review of a single institution’s experience, Skelet. Radiol. 43 (2014)
1079–1084.
[4] Y. Ragab, Y. Emad, T. Gheita, M. Mansour, A. Abou-Zeid, S. Ferrari, J.J. Rasker,
Differentiation of osteoporotic and neoplastic vertebral fractures by chemical
shift (in-phase and out-of phase) MR imaging, Eur. J. Radiol. 72 (2009) 125–133.
[5] W.K. Erly, E.S. Oh, E.K. Outwater, The utility of in-phase/opposed-phase imaging
on differentiating malignancy from acute benign compression fractures of the
spine, Am. J. Neuroradiol. 27 (2006) 1183–1188.
[6] E.K. Outwater, E.S. Siegelman, P.D. Radecki, C.W. Piccoli, D.G. Mitchell, Dis-
tinction between benign and malignant adrenal masses: value of T1-weighted
chemical-shift MR imaging, Am. J. Roentgenol. 165 (1995) 579–583.
[7] J.S. Yu, J.J. Chung, J.H. Kim, K.W. Kim, Fat-containing nodules in the cirrhotic
liver: chemical shift MRI features and clinical implications, Am. J. Roentegnol.
188 (2007) 1009–1016.
